1. Home
  2. SDGR vs DFIN Comparison

SDGR vs DFIN Comparison

Compare SDGR & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • DFIN
  • Stock Information
  • Founded
  • SDGR 1990
  • DFIN 1983
  • Country
  • SDGR United States
  • DFIN United States
  • Employees
  • SDGR N/A
  • DFIN N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • DFIN Other Consumer Services
  • Sector
  • SDGR Health Care
  • DFIN Consumer Discretionary
  • Exchange
  • SDGR Nasdaq
  • DFIN Nasdaq
  • Market Cap
  • SDGR 1.7B
  • DFIN 1.8B
  • IPO Year
  • SDGR 2020
  • DFIN N/A
  • Fundamental
  • Price
  • SDGR $22.23
  • DFIN $64.41
  • Analyst Decision
  • SDGR Buy
  • DFIN Strong Buy
  • Analyst Count
  • SDGR 5
  • DFIN 3
  • Target Price
  • SDGR $33.00
  • DFIN $68.67
  • AVG Volume (30 Days)
  • SDGR 1.1M
  • DFIN 202.9K
  • Earning Date
  • SDGR 08-06-2025
  • DFIN 07-31-2025
  • Dividend Yield
  • SDGR N/A
  • DFIN N/A
  • EPS Growth
  • SDGR N/A
  • DFIN N/A
  • EPS
  • SDGR N/A
  • DFIN 3.01
  • Revenue
  • SDGR $230,492,000.00
  • DFIN $779,600,000.00
  • Revenue This Year
  • SDGR $24.44
  • DFIN $1.99
  • Revenue Next Year
  • SDGR $22.17
  • DFIN $4.64
  • P/E Ratio
  • SDGR N/A
  • DFIN $21.38
  • Revenue Growth
  • SDGR 22.29
  • DFIN N/A
  • 52 Week Low
  • SDGR $16.60
  • DFIN $37.80
  • 52 Week High
  • SDGR $28.47
  • DFIN $71.01
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 53.21
  • DFIN 65.91
  • Support Level
  • SDGR $21.30
  • DFIN $60.87
  • Resistance Level
  • SDGR $23.75
  • DFIN $62.60
  • Average True Range (ATR)
  • SDGR 0.87
  • DFIN 1.41
  • MACD
  • SDGR 0.22
  • DFIN -0.23
  • Stochastic Oscillator
  • SDGR 57.78
  • DFIN 66.61

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: